Aadi bioscience appoints marcy graham senior vice president investor relations and corporate communications

Los angeles, may 31, 2022 (globe newswire) -- aadi bioscience, inc. (nasdaq: aadi), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mtor pathway genes, today announced the appointment of marcy graham to the new position of senior vice president, investor relations (ir) and corporate communications.
AADI Ratings Summary
AADI Quant Ranking